Trevi Therapeutics, Inc. (TRVI)

Market price: $13.35

1 valuation method

• P / B: $5.54 to $19.12 (midpoint $8.77)

Pre-profit company — earnings-based methods not meaningful.

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.